Shallow Whole-Genome Sequencing Improves Risk Stratification in Patients With MDS Rare Disease Advisor 23:05 Mon, 08 Jun
JAK2 Mutations More Prevalent, Linked to Improved OS in MDS/MPN Overlap Rare Disease Advisor 21:43 Mon, 08 Jun
Larrondo joins MDS Group’s Marine Insurance business as Global Director Reinsurance News 13:31 Fri, 05 Jun
Stelexis BioSciences Announces Positive Phase 1 Data for Eganelisib in Relapsed/Refractory AML and Higher-Risk Mds in an Oral Presentation at ASCO 2026 PR Newswire (Press Release) 15:34 Tue, 02 Jun
Eganelisib Shows Activity and Targets PI3Kγ in Higher-Risk MDS and AML Rare Disease Advisor 00:46 Tue, 02 Jun
Society of Hematologic Oncology opens registration for case-based Mds/AML program ahead of Soho 2026 PR Newswire (Press Release) 08:01 Wed, 27 May
Minister Joly announces $55 million Federal Investment to advance sustainable Canadian dual-use aerospace technology at MDS Coating Government of Canada (Press Release) 20:10 Wed, 13 May
Multi Derma System MDS 3000 Sets New Standard in Professional Skin Diagnostics cosmeticsbusiness.com 03:04 Wed, 13 May
Minister Joly to announce investment to advance sustainable aviation technologies at MDS Coating Technologies Government of Canada (Press Release) 17:46 Tue, 12 May
Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk Mds at EHA2026 and Announces Appointment of Han Myint, MD, Facp, as Chief Medical Officer PR Newswire (Press Release) 13:08 Tue, 12 May
